US FDA approves Tonix Pharma's drug to manage pain related to chronic condition-March 2024-www.financetom.com

US FDA approves Tonix Pharma's drug to manage pain related to chronic condition

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

US FDA approves Tonix Pharma's drug to manage pain related to chronic condition

Aug 15, 2025 1:15 PM

Aug 15 (Reuters) - The U.S. Food and Drug Administration

has approved Tonix Pharmaceuticals' ( TNXP ) drug to manage pain

related to a type of chronic condition, the company said on

Friday.

Previous page： AtriCure Shares Rise After Higher Q4, 2024 Revenue Projections; 2025 Revenue Outlook Set Next page： Brazil's Nubank partners with convenience store Oxxo to expand in Mexico

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

AtriCure Shares Rise After Higher Q4, 2024 Revenue Projections; 2025 Revenue Outlook Set

Jan 13, 2025

02:32 PM EST, 01/13/2025 (MT Newswires) -- AtriCure ( ATRC ) shares were up 8% in recent Monday trading after the company said it expects higher revenue for Q4 and fiscal 2024 from a year earlier. The company said it expects Q4 revenue of $124.3 million, up about 17% from a year earlier. Analysts polled by FactSet expect $120.4 million....

Brazil's Nubank partners with convenience store Oxxo to expand in Mexico

Jan 13, 2025

SAO PAULO (Reuters) - Brazilian digital lender Nubank has signed an agreement with Mexican convenience store chain Oxxo, run by FEMSA, to expand its cash deposit and withdrawal network in the North American country, the firms announced on Monday. WHY IT'S IMPORTANT Warren Buffett-backed Nubank, one of the Latin America's largest firms by market value, has been aiming to scale...

Sonida Senior Living Insider Bought Shares Worth $897,835, According to a Recent SEC Filing

Jan 13, 2025

02:34 PM EST, 01/13/2025 (MT Newswires) -- Michael Simanovsky, 10% Owner, Director, on January 08, 2025, executed a purchase for 42,111 shares in Sonida Senior Living ( SNDA ) for $897,835. Following the Form 4 filing with the SEC, Simanovsky has control over a total of 9,264,653 shares of the company, with 9,264,653 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1043000/000089534525000009/xslF345X05/form4.xml Price: 21.95,...

Piper Sandler Reviews Tilray's Q2

Jan 13, 2025

02:32 PM EST, 01/13/2025 (MT Newswires) -- Tilray reported US$211 million second-quarter revenue, missing Piper Sandler's US$222.2 million estimate. The company's second quarter revenue was up ~6% sequentially. Tilray expects fiscal 2025 sales of US$950 million to US$1 billion, which already included some M&A contribution. We believe TLRY stands out from competitors with direct access to the EU, but we...